Ausgabe 10/2019
Inhalt (12 Artikel)
Meta-analysis of Dropout Rates in Placebo-Controlled Randomized Clinical Trials of Atypical Antipsychotics Assessed by PANSS
Akiko Matsusaki, Masayuki Kaneko, Mamoru Narukawa
Oral Contraceptives and Neutropenia: A Population-Based Cohort Study
Yael Shalev Rosenthal, Gabi Chodick, Adam Rosenthal, Varda Shalev, Hila Shalev Ram, Gideon Koren
Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China
Jun Chen, Gaoyun Hu, Zhuo Chen, Xiaomin Wan, Chongqing Tan, Xiaohui Zeng, Zeneng Cheng
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy
Kouhei Nii, Yusuke Morinaga, Takafumi Mitsutake, Ritsurou Inoue, Toshio Higashi
HR+/HER2− Metastatic Breast Cancer: Epidemiology, Prescription Patterns, Healthcare Resource Utilisation and Costs from a Large Italian Real-World Database
Carlo Piccinni, Letizia Dondi, Giulia Ronconi, Silvia Calabria, Antonella Pedrini, Immacolata Esposito, Nello Martini, Maurizio Marangolo
Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults
Lihua Wu, Jian Liu, Yunliang Zheng, You Zhai, Meihua Lin, Guolan Wu, Duo Lv, Jianzhong Shentu
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects
Yutaro Maekawa, Hidetoshi Furuie, Manabu Kato, Yusuke Myobatake, Emi Kamiyama, Akiko Watanabe, Kazuhito Shiosakai, Takashi Taguchi, Robert Bass, Jin Zhou, Victor Dishy, Vance Warren, Vijay Vashi, Hitoshi Ishizuka
Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece
Theodoros V. Giannouchos, Dimos-Dimitrios Mitsikostas, Robert L. Ohsfeldt, Athanassios Vozikis, Paraskevi Koufopoulou
Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun, Kivanc Yuksel
Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report
Janet Pan
Mecapegfilgrastim in Chemotherapy-Induced Neutropenia: A Profile of Its Use in China
Zaina T. Al-Salama, Susan J. Keam
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Katherine A. Lyseng-Williamson